MROCKI: A Protein Targeted for Cancer and Neurodegenerative Diseases

Target Name: MROCKI

NCBI ID: G285758

MROCKI

Other Name(s): LINC01268 | ROCKI | MARCKS cis regulating lncRNA promoter of cytokines and inflammation

MROCKI: A Protein Targeted for Cancer and Neurodegenerative Diseases

MROCKI (LINC01268) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. It is a key regulator of the cell cycle, and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a drug target, MROCKI is being targeted by researchers to develop new treatments for these diseases.

One of the main functions of MROCKI is to regulate the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. MROCKI is a key regulator of the cell cycle, and is shown to play a role in the regulation of cell division, as well as the assembly and disassembly of the mitotic spindle.

In addition to its role in cell cycling, MROCKI has also been shown to play a role in the regulation of cell adhesion. cells are attached to each other through specialized adhesion molecules, and MROCKI is shown to regulate the formation and maintenance of these adhesion molecules. This has important implications for the development of diseases where cell-cell adhesion is disrupted, such as cancer.

Another function of MROCKI is its role in the regulation of cell signaling pathways. MROCKI has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and survival.

In addition to its role in cell signaling pathways, MROCKI has also been shown to play a role in the regulation of cellular transport. MROCKI is a protein that is involved in the transport of molecules into and out of cells, and is shown to play a role in the regulation of the movement of proteins into and out of cells. This has important implications for the development of diseases where the movement of molecules into and out of cells is disrupted, such as neurodegenerative diseases.

As a drug target, MROCKI is being targeted by researchers to develop new treatments for a variety of diseases. One of the main goals of targeting MROCKI is to disrupt its role in the regulation of the cell cycle, in order to encourage the growth and division of cancer cells. This is being done through the use of drugs that inhibit the activity of MROCKI, such as taxanes, which are commonly used to treat breast and ovarian cancers.

Another goal of targeting MROCKI is to disrupt its role in the regulation of cell signaling pathways, in order to inhibit the growth and survival of cancer cells. This is being done through the use of drugs that interfere with the activity of MROCKI, such as inhibitors of the TGF-β pathway.

In addition to its role in cancer, MROCKI is also being targeted for its role in the regulation of neurodegenerative diseases. Neurodegenerative diseases are a group of diseases that are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. MROCKI has been shown to play a role in the regulation of the movement of proteins into and out of cells, and is therefore being targeted as a potential drug target for these diseases.

In conclusion, MROCKI is a protein that is expressed in various tissues of the body, and is involved in the regulation of the cell cycle, cell adhesion, and cellular transport. It is also being targeted by researchers as a potential drug target for a variety of diseases, including cancer and neurodegenerative diseases. The development of new treatments for these diseases is being done through the use of drugs that inhibit the activity of MROCKI, and the continued research on its functions and potential uses will have important implications for the treatment of these diseases.

Protein Name: MARCKS Cis Regulating LncRNA Promoter Of Cytokines And Inflammation

The "MROCKI Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MROCKI comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets